Redox‐Respo n sive Tellurium‐Bridged Covalent Organic Frameworks/PEG Composites for Targeted Therapy of Diabetic Cardiomyopathy
Advanced Science · 2026-02 · 13 (7)
DOI: 10.1002/advs.202509298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 18.11.2025. Verfasst von Jing Xue und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, 230032, China. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Polyethylene Glycols, Tellurium, Metal-Organic Frameworks. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, International Cooperation and Exchange of the National Natural Science Foundation of China, Key Project of Natural Science Research of the University in Anhui Provence.
Abstract (Originalsprache)
Diabetic cardiomyopathy, a major complication of diabetes, is strongly associated with elevated levels of glycated hemoglobin (HbA1c) and reactive oxygen species (ROS). However, effective clinical strategies to simultaneously lower HbA1c and ROS levels remain elusive, primarily due to the lack of therapeutic agents that can efficiently and synergistically interact with both biological macromolecules and small reactive molecules. To tackle this challenge, a redox‐responsive tellurium‐bridged covalent organic framework (Te‐COF) is developed whose surface is functionalized with hydrazine‐bonded polyethylene glycol (PEG), yielding a series of three emissive Te‐COF@PEG nanocomposites with varying PEG molecular weights (Te‐COF@PEG, M W = 600, 2000, 6000 Da). In vitro studies demonstrate that Te‐COF@PEG composites efficiently remove HbA1c and total glycated protein from the plasma of diabetic patients, significantly lowering blood glucose levels without affecting serum levels of total proteins, lipids, and apolipoproteins. Among the composites, Te‐COF@PEG2000 exhibits the most promising therapeutic effects in diabetic mouse and rabbit models, including a significant reduction in fasting blood glucose, HbA1c, and inflammatory factor levels. Importantly, Te‐COF@PEG2000 induces macrophage polarization towards M2 phenotype, inhibits cardiomyocyte apoptosis, scavenges excess ROS, and synergistically improves myocardial injury. This study unlocks the immense potential of COF@polymer nanocomposites as a multifunctional platform for targeted diabetic cardiomyopathy therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
- Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, 230032, China.
- Department of Functional Experiment Center, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
- Department of Endocrinology, First Affiliated Hospital, Anhui Medical University, Hefei, 230032, China.
- College of Chemical and Pharmaceutical Engineering, Hefei Normal University, Hefei, 230601, China.
ORCID-Profile: Guiyang Zhang
Förderung
- National Natural Science Foundation of China
- International Cooperation and Exchange of the National Natural Science Foundation of China
- Key Project of Natural Science Research of the University in Anhui Provence
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Xue, J., Zhuang, J., Fan, T., Tang, S., Wang, J., Liu, X., Liu, J., Shi, J., Li, J., Li, W., Hu, D., Zhang, X., Wang, H., & Zhang, G. (2026). Redox‐Respo n sive Tellurium‐Bridged Covalent Organic Frameworks/PEG Composites for Targeted Therapy of Diabetic Cardiomyopathy. Advanced Science, 13(7). https://doi.org/10.1002/advs.202509298
Vancouver
Xue J, Zhuang J, Fan T, Tang S, Wang J, Liu X, et al. Redox‐Respo n sive Tellurium‐Bridged Covalent Organic Frameworks/PEG Composites for Targeted Therapy of Diabetic Cardiomyopathy. Advanced Science. 2026;13(7). doi:10.1002/advs.202509298
BibTeX
@article{Xue2026,
author = {Xue, Jing and Zhuang, Jialu and Fan, Taotao and Tang, Songtao and Wang, Junjun and Liu, Xiaohui and Liu, Jian and Shi, Jin and Li, Jiaji and Li, Wanjun and Hu, Danyou and Zhang, Xiaoqian and Wang, Hua and Zhang, Guiyang},
title = {Redox‐Respo n sive Tellurium‐Bridged Covalent Organic Frameworks/PEG Composites for Targeted Therapy of Diabetic Cardiomyopathy},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {7},
doi = {10.1002/advs.202509298}
}
EUVIMED